The foundation is already planning a follow-up investment trip to Stockholm in July to meet several companies on the list.
“We’ve seen growing international interest in the Hotlist for a while. The fact that even the Gates Foundation has become aware of the investment opportunities confirms Stockholm’s image as an innovative and leading life science region,” says Ylva Hultman, Stockholm Business Region Development.
The Life Science Hotlist is curated by Stockholm Business Region Development. The list is a tool for investors focused on disruptive commercial innovation in life science. To qualify for the list, the companies must offer a product or service based on unique academic research that will lead to a commercial solution with global potential. They must also have established themselves in the market with a finished product or service, alternatively, be close to the commercialization phase.